Source:http://linkedlifedata.com/resource/pubmed/id/16391196
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2006-1-4
|
pubmed:abstractText |
Tumor-induced angiogenesis can be targeted by RGD (Arg-Gly-Asp) peptides, which bind to alpha(v)beta(3)-receptors upregulated on angiogenic endothelial cells. RGD-containing peptides are capable of inducing apoptosis through direct activation of procaspase-3 to caspase-3 in cells. Additionally, tumor cells overexpressing somatostatin receptors can be targeted by somatostatin analogs. Radiolabeled somatostatin analogs are successfully used to image and treat such tumors via receptor-targeted scintigraphy and therapy. We combined these 2 peptides, RGD and somatostatin, to synthesize a new hybrid peptide, RGD-diethylenetriaminepentaacetic acid (DTPA)-octreotate (c(Arg-Gly-Asp-D-Tyr-Asp)-Lys(DTPA)-D-Phe-c(Cys-Tyr-D-Trp-Lys-Thr-Cys)-Thr). An earlier study showed that tumor-bearing rats had high receptor-specific uptake of RGD-(111)In-DTPA-octreotate in somatostatin receptor subtype 2-positive tissues and tumors. Furthermore, RGD-(111)In-DTPA-octreotate showed a pronounced tumoricidal effect, which is probably the result of increased apoptosis, as is shown by an increased caspase-3 activity after incubation with (111)In-labeled RGD-DTPA-octreotate in comparison with the 2 monopeptides (111)In-DTPA-RGD and (111)In-DTPA-Tyr(3)-octreotate. In this study, we evaluated the biodistributions of RGD-(111)In-DTPA-octreotate and (125)I-RGD-octreotate and investigated the caspase-3 activation of the unlabeled compound RGD-DTPA-octreotate in vitro.
|
pubmed:grant | |
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Apoptosis Regulatory Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Indium Radioisotopes,
http://linkedlifedata.com/resource/pubmed/chemical/Oligopeptides,
http://linkedlifedata.com/resource/pubmed/chemical/Radiopharmaceuticals,
http://linkedlifedata.com/resource/pubmed/chemical/arginyl-glycyl-aspartic acid
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0161-5505
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
47
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
122-9
|
pubmed:dateRevised |
2007-12-3
|
pubmed:meshHeading |
pubmed-meshheading:16391196-Animals,
pubmed-meshheading:16391196-Antineoplastic Agents,
pubmed-meshheading:16391196-Apoptosis Regulatory Proteins,
pubmed-meshheading:16391196-Drug Delivery Systems,
pubmed-meshheading:16391196-Indium Radioisotopes,
pubmed-meshheading:16391196-Male,
pubmed-meshheading:16391196-Metabolic Clearance Rate,
pubmed-meshheading:16391196-Oligopeptides,
pubmed-meshheading:16391196-Organ Specificity,
pubmed-meshheading:16391196-Pancreatic Neoplasms,
pubmed-meshheading:16391196-Radioimmunotherapy,
pubmed-meshheading:16391196-Radiopharmaceuticals,
pubmed-meshheading:16391196-Rats,
pubmed-meshheading:16391196-Rats, Inbred Lew,
pubmed-meshheading:16391196-Tissue Distribution,
pubmed-meshheading:16391196-Treatment Outcome
|
pubmed:year |
2006
|
pubmed:articleTitle |
Anticancer activity of targeted proapoptotic peptides.
|
pubmed:affiliation |
Department of Nuclear Medicine, Erasmus MC, Rotterdam, The Netherlands.
|
pubmed:publicationType |
Journal Article,
Research Support, N.I.H., Extramural
|